Literature DB >> 18505416

Insulin resistance in experimental alcohol-induced liver disease.

Suzanne M de la Monte1, Jong-Eun Yeon, Ming Tong, Lisa Longato, Rajeev Chaudhry, Mao-Yin Pang, Kevin Duan, Jack R Wands.   

Abstract

BACKGROUND AND AIM: Chronic ethanol consumption impairs liver regeneration due, in part, to inhibition of insulin signaling. This study characterizes the mechanisms and consequences of ethanol-impaired insulin signaling in relation to oxidative injury and altered gene expression.
METHODS: Long-Evans rats were fed for 8 weeks with isocaloric liquid diets containing 0% (control) or 37% ethanol (caloric content). Livers were used to examine histopathology, indices of oxidative stress, gene expression required for insulin and insulin-like growth factor (IGF) signaling, insulin-responsive gene expression, i.e. glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and aspartyl-asparaginyl-beta-hydroxylase (AAH), and competitive equilibrium binding to the insulin, IGF-I, and IGF-II receptors.
RESULTS: Chronic ethanol exposure caused liver injury with increased hepatocellular steatosis, inflammation, apoptosis, and increased immunoreactivity for activated caspase-3, 8-hydroxy-2'-deoxyguanosine, and 4-hydroxy-2,3-nonenol. These effects were associated with increased expression of IGF-I receptor, IGF-II, and IGF-II receptor, and expression of IGF-I, AAH, and GAPDH, which mediate energy metabolism and cell motility/remodeling, and reduced binding to the insulin receptor.
CONCLUSIONS: Chronic ethanol-induced liver injury causes insulin resistance with inhibition of insulin-responsive genes needed for metabolism, remodeling, and regeneration. In contrast, the IGF-I and IGF-II signaling mechanisms remain relatively preserved, suggesting that insulin-regulated hepatic functions may be selectively vulnerable to the toxic effects of ethanol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505416     DOI: 10.1111/j.1440-1746.2008.05339.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  45 in total

1.  Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance.

Authors:  Suzanne M de la Monte; Maoyin Pang; Rajeev Chaudhry; Kevin Duan; Lisa Longato; Jade Carter; Jiyun Ouh; Jack R Wands
Journal:  Hepatol Res       Date:  2011-02-24       Impact factor: 4.288

2.  Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.

Authors:  Diana Lizarazo; Valerie Zabala; Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

3.  Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ Agonist.

Authors:  Chelsea Q Xu; Suzanne M de la Monte; Ming Tong; Chiung-Kuei Huang; Miran Kim
Journal:  Alcohol Clin Exp Res       Date:  2015-04-23       Impact factor: 3.455

4.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

5.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

Review 6.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

Review 7.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

8.  Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.

Authors:  Sarah M Denucci; Ming Tong; Lisa Longato; Margot Lawton; Mashiko Setshedi; Rolf I Carlson; Jack R Wands; Suzanne M de la Monte
Journal:  Gastroenterol Res Pract       Date:  2010-08-16       Impact factor: 2.260

9.  Small-fiber degeneration in alcohol-related peripheral neuropathy.

Authors:  Michelle L Mellion; Elizabeth Silbermann; James M Gilchrist; Jason T Machan; Lorenzo Leggio; Suzanne de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

Review 10.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.